30
Participants
Start Date
April 12, 2021
Primary Completion Date
May 3, 2021
Study Completion Date
May 3, 2021
PBI-100 Topical Cream
A dose of approximately 560 ug (approximately 0.4 mL of each of the three concentrations to 3 different sites) of PBI-100 was applied daily (excluding weekends) to the skin test sites.
Positive Control - Sodium laurel sulfate (SLS)
Approximately 0.4 mL of 0.25% SLS was applied daily (excluding weekends) as a positive control test site.
PBI-100 Topical Cream, Vehicle
Approximately 0.4 mL of 0% placebo cream was applied daily (excluding weekends) as a positive control test site.
Negative Control
A blank patch was applied daily (excluding weekends) as a negative control test site.
KGL Skin Study Center, Newtown Square
Lead Sponsor
Pyramid Biosciences
INDUSTRY